Register here

Date

Tuesday, February 7th 2023

Location

Avenue d'Écolys 2, 5020 Namur, België

Price

€0 for non-members

€0 for members

Language

English

Organised by

Deloitte & BioWin

Categories

Tags

Start the digitalization of your existing bioprocessing assets

Abstract

As is true for most industries, digital transformation is no longer a buzzword, but a strategic imperative for life sciences companies. While first movers would likely gain a competitive advantage, all of today’s companies risk falling behind their competitors in delivering across all elements of the value chain if their strategies are limited to a few pilots and experiments. Digital transformation is a journey and should enable your strategic objectives and help you to execute it efficiently, engage effectively with your eco-system and innovate.

Join this workshop to get answers to these questions:

  • What are the digital market trends in biopharma companies?

  • What could be the key digital use cases of your digital journey?

Key Learning Objectives

  • Learn market trends of your industry regarding digital transformation

  • Share an overview of valuable use cases to achieve your strategic objectives

  • Share and discuss challenges that a Manufacturing Execution System (MES) could address through one specific example (context, objectives, results & lessons learned)

  • Share and discuss solutions used to manage and optimize energy consumption through one specific example (context, objectives, results & lessons learned)


Speakers

Sophie Hoste - Consulting Partner at Deloitte
Ward Maertens - Senior Manager | Supply Chain & Network Operations at Deloitte
Fabian Camacho Loyola - Manager | Cloud & Engineering at Deloitte

_______________

We hope to see many of you at this session, to discuss the unavoidable need to increase the awareness and support of our ecosytem in its digital evolution.